Surveillance and oseltamivir resistance of human influenza A virus in Turkey during the 2007-2008 season

Journal of Medical Virology

Volumn 81, Issue 9, 2009, Pages 1645-1651

  Ciblak, Meral Akcay ^a,e   Hasoksuz, Mustafa ^b   Escuret, Vanessa ^c,d   Valette, Martine ^c,d   Gul, Fadime ^a   Yilmaz, Huseyin ^b   Turan, Nuri ^b   Bozkaya, Emel ^a   Badur, Selim ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c UNIVERSITÉ DE LYON   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e YEDITEPE UNIVERSITY   (Turkey)

Author keywords

H1N1; Human influenza A; Oseltamivir resistance; Sequencing; Surveillance; Turkey

Indexed keywords

OSELTAMIVIR;

AMINO ACID SEQUENCE; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; NONHUMAN; RNA EXTRACTION; TURKEY (REPUBLIC); VIRUS ISOLATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 68949131180     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21546     Document Type: Article

References (18)

1. Bouvier NM, Lowen AC, Palese P. 2008. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J Virol 82:10052-10058.
2. CDC. 2008. Influenza activity United States and worldwide, 2007- 2008 season. Morbid Mortal Wkly Rep 57:692-697.
3. Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, Lina B, Morfin F, Ferraris O. 2008. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol 41:25-28.
4. European Influenza Surveillance Scheme. 2007. Annual report: 2005-2006 influenza season. The Netherlands: Utrecht.
5. Ferraris O, Kessler N, Lina B. 2005. Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Antiviral Res 68:43-48. (Pubitemid 41338581)
6. Gubareva LV. 2004. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 103:199-203. (Pubitemid 38649080)
7. Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, Monto S. 2004. Influenza viruses resistant to the antiviral drug oseltamivir: Transmission Studies in Ferrets. J Infect Dis 190: 1627-1630. (Pubitemid 39411012)
8. Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA. 2002. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55:307-317. (Pubitemid 34718130)
9. Kilbourne ED. 2006. Influenza pandemics of the 20th century. Emerg Infect Dis 12:9-13.
10. McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F, Zambon M. 2003. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 47: 2264-2272. (Pubitemid 36753582)
11. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M,Webster RG, AymardM, Hayden FG, Zambon M. 2006. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50:2395-2402. (Pubitemid 43993177)
12. Mungall BA, Xu X, Klimov A. 2004. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000- 2002 influenza seasons. Virus Res 103:195-197. (Pubitemid 38649079)
13. Onal A, Aslan S, Bozkaya E, Badur S. 2006. Influenza surveillance in Turkey during 2003-2004 and 2004-2005 years and typing of influenza strains isolated. Klin J 19:3-9.
14. Oxford JS. 2007. Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza Other Respir Viruses 1:27-34.
15. Rameix-Welti MA, Enouf V, Cuvelier F, Jeannin P, van der Werf S. 2008. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog 4:e1000103.
16. Schweiger B, Zadow I,Heckler R,TimmH, PauliG. 2000. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol 38:1552-1558.
17. Taubenberger JK, Morens DM. 2006. 1918 influenza: The mother of all pandemics. Emerg Infect Dis 12:15-22.
18. Wright KE, Wilson GA, NovosadD, Dimock C, TanD,Weber JM. 1995. Typing and sub-typing of influenza viruses in clinical samples by PCR. J Clin Microbiol 33:1180-1184.